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Summary 
Blood neutrophils contribute to joint injury in human and experimental models of arthritis. 
Neutrophil migration out of the blood in joint inflammation involves both the CD18 (132) in- 
tegrins and a CD18 integrin-independent pathway. To investigate this migration, radiolabeled 
rat blood neutrophils were used to measure neutrophil accumulation in the inflamed  joints of  rats 
with adjuvant arthritis and the role of leukocyte integrins in migration to these joints and to 
dermal inflammation was  determined.  Neutrophils migrated rapidly (<2  h)  to the inflamed 
joints 14--18  d after immunization with adjuvant. Blocking monoclonal antibodies (mAbs)  to 
both LFA-1 and Mac-1 together, as well as a mAb to CD18, inhibited neutrophil accumulation 
in the inflamed joints by 50-75%.  However, migration to dermal inflammation induced by 
C5aae~ ~g, tumor necrosis factor cx, lipopolysaccharide, and poly-inosine:cytosine was inhibited 
by ~90%. Flow cytometry revealed the expression of  low levels of  very late antigen 4 (VLA-4) on 
nearly all rat blood neutrophils. Treatment with anti-VLA-4 plus anti-LFA-1 but neither mAb 
alone, strongly (60-75%) inhibited neutrophil accumulation in arthritic joints. This mAb com- 
bination  also  inhibited  neutrophil migration  to  dermal inflammatory reactions by 30-70%. 
Blocking VLA-4 together with the CD18 integrins inhibited neutrophil accumulation by 95-99%, 
virtually abolishing neutrophil accumulation in cutaneous inflammation. A similar blockade of 
VLA-4 and CD18 decreased neutrophil accumulation in the inflamed joints by 70-83%, but a 
significant portion of the neutrophil accumulation to these joints still remained. In conclusion, 
rat blood neutrophils express functional VLA-4 that can mediate neutrophil migration to both 
inflamed joints and dermal inflammatory sites. VLA-4 appears to be able to substitute for LFA-1 
in this migration and is particularly important for accumulation in inflamed joints. However, 
there exists an additional CD18- and VLA-4-independent pathway of neutrophil migration to 
arthritic joints that is not involved in acute dermal inflammation. 
M 
igration of leukocytes out of the blood into inflam- 
matory tissues is governed by a complex series of ad- 
hesive events involving selectins, sialomucin glycoproteins, 
and integrins on the leukocyte that control leukocyte at- 
tachment to the vascular endothelium (1, 2). The integrins 
are a family of cell surface molecules that mediate ceil-cell 
and ceU-extracellular matrix adhesion (3). Each of  the inte- 
grins consists  of an o#13 heterodimer that binds to one or 
more ligands.  Lymphocytes express CD1 la/CD18 (LFA-1) 
and  several  [31  integrins,  including o~4131 (CD49d/CD29, 
very late  antigen  4  [VLA-4]I).  These  receptors  mediate 
1Abbreviations used in this paper: i.d., intradermal; poly I:C, poly-inosine: 
cytosine; VLA-4, very  late antigen 4; ZAS, zymosan-activated  serum. 
lymphocyte adhesion to vascular endothelial cells and the mi- 
gration oflymphocytes into cutaneous inflammatory reactions 
(4--7).  Monocytes express three integrins sharing in com- 
mon the 132 (CD18)  chain, Ixc132 (LFA-1), IXM132 (CDllb/ 
CD18,  Mac-l),  and  C~xl32 (CD11c/CD18,  p150,95),  as 
well as the  13~  integrin, VLA-4. The CD18  integrins and 
VLA-4 have been shown to mediate monocyte--endothelial 
cell adhesion and transendothelial migration in vitro, and in 
vivo monocyte migration to inflammation in the skin, peri- 
toneum, and inflamed joints (8-10). Blood neutrophils ex- 
press high levels of the CD18 integrins, LFA-1, Mac-l, and 
p150,95,  and  these  mediate  neutrophil-endothelial adhe- 
sion and migration to inflammation in the skin, in the lung, 
and in ischemic reperfusion injury (11-15). There is also, 
however,  evidence  that  neutrophils  can  infiltrate  lungs, 
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mechanism (10,  14,  16). 
Recent  studies have  also suggested that  human  neutro- 
phils may also express some 13 l integrins. Neutrophil adher- 
ence  to  laminin is  mediated by ot613  ~ (VLA-6),  and  these 
cells  can  bind  to  fibronectin  via  o~s[31 (VLA-5;  17,  18). 
During  myelopoesis,  neutrophils  also  express  VLA-4,  al- 
though human blood neutrophils are thought to express lit- 
tle or no VLA-4 (19). 
Previously, our laboratory demonstrated that neutrophil 
migration to inflammation induced with a variety of agents 
(C5a,  TNF-c~,  IL-1,  and  LPS)  was  strongly inhibited  by 
blocking the CD18  integrins, LFA-1 and Mac-1  (13).  On 
the other hand,  the migration of blood neutrophils to in- 
flamed joints was only partially (50--70%) CD 18 dependent 
(16).  This  suggested  that  an  alternate  adhesion  pathway 
may be responsible for part of the migration of neutrophils 
from the blood into these tissues. Since virtually all of the 
migration of monocytes into  inflamed joints  could be in- 
hibited by combined blockade of the CD18  integrins and 
VLA-4  (9),  we  reasoned  that  neutrophils  may  also  use 
VLA-4 for migrating to inflamed joints. 
Our  results  demonstrate  that  rat  blood neutrophils  ex- 
press  low  levels of VLA-4,  and  that  this  VLA-4  is  func- 
tional. VLA-4 can mediate a part of the neutrophil migra- 
tion to inflammatory reactions in the skin, and it plays an 
important  role  in  the  accumulation  of neutrophils  in  in- 
flamed joints. Furthermore, there exists an additional com- 
ponent  of neutrophil accumulation in arthritis that is both 
CD18 and VLA-4 independent. 
Materials and Methods 
Animals.  Adjuvant arthritis was induced in  6-8-wk-old in- 
bred male Lewis strain rats by immunization on the lower back 
with  1.0  mg Mycobacterium butyricum (Difco Laboratories,  Inc., 
Detroit, MI) in 0.1  ml mineral oil subcutaneously at the base of 
the tail.  These animals developed polyarticular arthritis 10-11  d 
after immunization, and were studied between days 14 and 16. 
PMN Isolation and Labeling.  Rat blood neutrophils (PMNs) for 
migration studies were  obtained using  the  hydroxyethyl-starch 
exchange transfusion technique of  Williams et al. (20) as modified 
by us previously (13). Briefly, the total blood volume of a donor 
rat  was  exchanged  using  50  ml  6%  hydroxyethyl-starch-saline 
(Dupont Chemical Co., Dorval, Quebec, Canada). After the col- 
lection of 40-50 ml blood hydroxyethyl-starch perfusate, eryth- 
rocytes were allowed to sediment at  1 g and the leukocyte-rich 
plasma was collected. The leukocytes were recovered by centrifu- 
gation,  resuspended in  calcium magnesium-free Tyrode's solu- 
tion plus 10% platelet-poor plasma (Tyr-10% PPP),  and layered 
onto  63%  isotonic Percoll (Pharmacia Fine Chemicals, Dorval, 
Quebec, Canada) layered above 74% Percofl. After centrifugation 
(400 g for 30 rain), the mononuclear layer on the top of the 63% 
Percoll was removed, and the purified neutrophils at the 63/74% 
interface were recovered. This layer consisted of >98% granulo- 
cytes with  minimal  erythrocyte contamination  and  was  >98% 
viable  by  Trypan  blue  dye  exclusion.  The  neutrophils  were 
washed and incubated for 10 min with 1 b~Ci 111In oxine (Amer- 
sham, Inc., Oakville, ON, Canada) per 107 cells. These cells were 
washed twice and resuspended for i.v. injection. Each rat received 
107 labeled PMNs carrying 2-5 3<  105 cpm. 
The functional integrity of these PMNs was demonstrated by 
very active accumulation of labeled cells in dermal inflammatory 
reactions and the retention of >95% of the label on the cells in 
the  circulation after i.v.  injection,  as  reported previously (21). 
The  purified neutrophils also  showed no  significant (<6%)  in- 
crease in Mac-1 expression as measured by immunofluorescence 
flow cytometry compared with PMNs in blood. 
mAbs and Ab Treatment.  The mAb MRC OX-42 was a kind 
gift from Dr. D.W. Mason (University of Oxford, Oxford, UK). 
It is a mouse IgG2a mAb that reacts with CDllb of rat Mac-I 
and blocks its adhesive functions, as previously shown (13). It was 
used as the F(ab)2 fragment generated by pepsin digestion. The 
TA-3 mAb is an IgG1 mAb that reacts with the ci chain of rat 
LFA-1 and blocks its function  (6).  The  TA-2 mAb is an  IgG1 
mAb that reacts with (x  4 and blocks in vitro adhesion and in vivo 
lymphocyte and monocyte migration mediated by VLA-4 (8, 9, 
22, 23).  The WT.3 mAh is an IgG1 mAb that reacts with the [3 
chain (CD18) of the rat [32 integrins and blocks its function (24). 
Control mAbs included 2CB4E1  (IgG2a) which was generated 
in our laboratory and reacts with rat neutrophils to approximately 
the same intensity as a  saturating concentration  of OX-42  and 
TA-3, as determined by flow cytometry. It immunoprecipitates a 
65-kD polypeptide from rat leukocytes, mAb B9  (IgGl), which 
reacts with pertussis toxin, was also used as a nonbinding control 
mAb (25).  Since the results  with these control mAbs were com- 
parable, these measurements were pooled. All of the mAbs were 
grown in ascites  in mice, and ammonium  sulphate-precipitated 
IgG was used. 
The  effect of the rnAbs on neutrophil migration in vivo was 
determined by giving animals an i.v. injection of 1-2 mg TA-2, 
TA-3, or WT.3 IgG, or the F(ab)2 fragment of OX-42, immedi- 
ately before i.v.  injection of labeled neutrophils.  None  of the 
mAb  treatments  caused  neutropenia  or  clearance  of the  J11In- 
labeled neutrophils from the circulation when compared with an- 
imals not receiving any Abs. 
Dermal Inflammatory Reactions.  Inflammatory reactions, which 
we  have previously shown  to  induce  neutrophil accumulation, 
were induced in rats by intradermal (i.d.)  injection (13, 26).  Re- 
combinant mouse  TNF-oL  was  kindly provided by Genentech, 
Inc. (South San Francisco, CA). Escherichia coli LPS was from List 
Biologicals (Campbell, CA). Zymosan-activated serum (ZAS), a 
source of C5aae~ Arg chemotactic factor, was generated by activat- 
ing C' in normal rat serum with 5 mg/ml ofZymosan A  (Sigma 
Chemical Co., St. Louis, MO) for 60 rain at 37~  and removing 
the zymosan as described previously (27).  Poly-inosine:cytosine 
(poly I:C) was obtained from Sigma Chemical Co. 
Measurement of Neutrophil Migration.  Rats previously immunized 
with M.  butyricum to induce adjuvant arthritis were anesthetized 
and injected intravenously with 11~In-labeled neutrophlls. Imme- 
diately afterward, the skin on the back of the animals was shaved 
and inflammatory stimuli in a volume of 0.05  rnl were injected 
intradermaUy into several sites along with diluent controls.  2  h 
later, the animals were euthanized and blood was collected in acid 
citrate dextrose anticoagulant. The dorsal skin, including the area 
of dermal inflammatory reaction, was removed and frozen;  the 
injected skin sites were punched out with a  12-mm punch  and 
counted in a gamma spectrometer. The forelimbs were sectioned, 
leaving the forepaws (containing the metacarpal and phalangeal 
joints) and the carpal joints as separate samples for gamma count- 
ing. Similarly, the hind limbs were sectioned just above and be- 
low the tibiotalar  joint, providing hindpaws (containing metatar- 
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red blood cells in 1 ml of blood were lysed with 0.84% NH4C1, 
the  leukocytes pelleted by  centrifugation,  and  the  number  of 
neutrophils and rain content of the cells determined. The accu- 
mulation of 11qn-neutrophils is expressed as the number of neu- 
trophils ￿  10  ~  per tissue calculated from the blood neutrophil- 
specific activity. 
Statistical Methods.  Differences  between  groups  were  tested 
using a one-way analysis of variance and posthoc testing with the 
Tukey-Kramer Multiple Comparisons Test. 
Results 
Effect of mAbs to LFA- 1,  Mac- 1,  and  CD 18 on Neutrophil 
Accumulation  in Arthritic Joints.  To  evaluate the role of the 
CD18  integrins  in  neutrophil  accumulation  in  arthritic 
joints,  animals were  studied  14-18  d  after immunization, 
when the joints were markedly inflamed. Animals received 
an i.v. injection of mAb OX-42  to Mac-l, mAb TA-3 to 
LFA-1, the  combination  of both  of these  mAbs,  or mAb 
WT.3 to CD18,  or a control mAb, and immediately after- 
ward,  an  injection  of lnln-labeled  neutrophils.  Animals 
were killed 2 h  later. As shown in Fig. 1, there was consid- 
erable neutrophil accumulation in the joints of the animals 
receiving  the  control  mAb  treatment  with  ~-,16  million 
neutrophils accumulating in the  talar joint, which was the 
most severely affected, and 2-4 million in the other joints. 
Treatment with mAb to Mac-1  or to LFA-1 had no signif- 
icant effect on neutrophil accumulation in any of the joints, 
although there was some decrease in neutrophil accumula- 
tion in the talar joints of animals treated with anti-LFA-1. 
The  combination of rnAbs to  Mac-1  and  LFA-1  strongly 
inhibited neutrophil accumulation  to  the  large talar joints 
and  also  significantly reduced  accumulation  in  the  hind- 
paw,  carpal,  and  forepaw joints.  Treatment  of rats  with 
mAb to  CD18  had a  similar inhibitory effect. Both  com- 
bined LFA-1 and Mac-1  blockade, or CD18 blockade, in- 
hibited  neutrophil  accumulation  in  the  talar  joints  by 
"~  and in the hindpaw and carpal joints by "-'50%. 
Effect of mAb  to LFA-I,  Mac-l,  and  CD18  on Neutrophit 
Migration  to Cutaneous  Inflammation.  To  compare  the  role 
of the CD18  integrins in neutrophil migration to inflamed 
joints with inflammation in the skin, the same animals in- 
jected  with  mAb  and  labeled neutrophils  for  the  experi- 
ments in Fig. 1 were injected intradermally with stimuli to 
induce a dermal inflammatory reaction. As shown in Fig. 2, 
rats were injected with ZAS, a source ofC5aae  s Arg, TNF-ot, 
LPS, and poty I:C, a potent cytokine inducer. Anti-Mac-1 
had no effect on neutrophil accumulation to any of the in- 
flammatory reactions. Anti-LFA-1 alone caused a small in- 
hibition of neutrophil accumulation to poly I:C, but much 
more  dramatic  inhibition  was  induced  by  blocking  the 
combination of both Mac-1  and LFA-1. The  combination 
of anti-Mac-1  and  anti-LFA-1  inhibited  80-90%  of the 
neutrophil  accumulation,  and  treatment  with  anti-CD18 
inhibited >90% of the migration to the four inflammatory 
stimuli. Doubling the dose of the mAb treatment did not fur- 
ther suppress neutrophil accumulation. Thus, neutrophil accu- 
Figure 1.  The effect of treatment with  mAb to LFA-1, Mac-l, and 
CD18 on neutrophil migration to arthritic joints. P-ats with polyarticular 
arthritis between days 14 and 16 after immunization were injected intra- 
venously with control mAb (2CB4E1 or B9), anti-Mac-1  (mAb MRC 
OX-42),  anti-LFA-1  (mAb TA-3),  a combination  of anti-LFA-1 plus 
anti-Mac-I, or anti-CD18  (mAb WT-3) as indicated. Immediately after- 
ward, the animals were injected with lnln-labeled blood neutrophils. 2 h 
later, the rats were euthanized and m ln-neutrophil accumulation was de- 
termined. Values are mean +  SEM of 5-17 animals in each group. Values 
for background neutrophil accumulation in corresponding joints of nor- 
mal nonarthritic animals were 0.34 ￿  106 PMN/talar joint, 0.26 ￿  106 
PMN/hindpaw,  0.14 ￿  106 PMN/carpal joint, and 0.07  ￿  106 PMN/ 
forepaw. +P <0.05,  ~P <0.01,  *P <0.001. 
mulation  to  dermal  inflammation was  strongly suppressed 
(>90%)  by blocking CD18  integrins,  whereas  accumula- 
tion  in  inflamed  joints  was  inhibited  only  by  50-75%. 
Therefore,  the contribution of VLA-4 to this latter migra- 
tion was investigated. 
Immunofluorescence Analysis of Neutrophil  Staining  with Anti~ 
VLA-4.  Fig. 3 shows that the TA-2 mAb to VLA-4 stained 
nearly all blood neutrophils. Although the intensity of the 
staining was relatively low, it was  clearly greater than that 
of the isotype-matched negative control mAb. 
Effect of mAb to  VLA-4,  LFA-1,  and Mac-1  on Neutrophil 
Accumulation  in Arthritic Joints.  Rats were treated with anti- 
VLA-4, anti-LFA-1, both of these mAbs, or control mAb, 
and neutrophil migration to  the talar, hindpaw,  and carpal 
joints was determined (Fig. 4). Anti-eq by itself had no ef- 
fect on neutrophil accumulation, but when combined with 
anti-LFA-1, it strongly inhibited neutrophil accumulation 
2177  Issekutz et al. 120 
110 
100 
80 
~  70 
50 
~  4o 
10  -  * 
0 
ZAS  TN  F  LPS  PIG 
Anti-Mac-1  ~  AntI-Mac-I+LFA-I 
Anti-LFA-1  ~  Anti-CO18 
Figure  2.  The  effect of treatment  with 
mAb to Mac-l, LFA-1, and CD18 on neu- 
trophil  migration  to  dermal inflammation. 
In the animals in Fig. 1, immediately after 
i.v. injection of the mAbs and 111In-labeled 
neutrophils,  cutaneous  inflammatory  reac- 
tions were induced by i.d. injection of 50% 
ZAS,  1  ng  of  endotoxin  (LPS), 10  ng 
mouse TNF-u, and 200 ng poly I:C (PIC) 
per site. The labeled cells were  allowed to 
accumulate in the skin sites for 2 h, while at 
the same time they were  also migrating to 
the inflamed joints.  Each bar represents the 
mean percentage  of the control  antibody- 
treated animals +  SEM with 5-17 animals 
per group. The neutrophil accumulation in 
the control animals was 3.65 ￿  106 PMN/ 
site  for  ZAS,  3.08  ￿  106  PMN/site  for 
TNF-c~, 3.24 ￿  106 PMN/site for LPS, and 
1.14 ￿  106 PMN/site for poly I:C. Values 
of control diluent injected sites were 0.08- 
0.13 ￿  106  "  *  PMN/slte.  P <0.001. 
in all three joints. The talar and carpal joints were inhibited 
by 75%, and the hindpaw by 60%.  In all cases, blocking cx  4 
was more inhibitory than anti-LFA-1 alone. 
Fig.  5  shows  that blocking Mac-1  in combination with 
anti-VLA-4,  unlike blocking LFA-1,  did not significantly 
inhibit  neutrophil  accumulation  in  the  inflamed  joints. 
10  1  10  2 
Anti.CD49d -> 
10 z 
Figure 3.  Flow cytometry analysis of immunofluorescence-stained  rat 
blood neutrophils were stained with the anti-VLA-4 (CD49d) mAb TA-2 
(solid histogram), or an isotyped-matched control mAb (B9), washed, and 
stained with streptavidin-conjugated phycoerythrin.  Cells were analyzed 
by flow cytometry and one representative result of five similar assays is 
shown.  The neutrophils  were  found to be >90% positive for staining 
with anti-CD49d. 
There  was  a  tendency for less neutrophil accumulation in 
the presence of dual Mac-1 VLA-4 blockade, but this effect 
was not significant. 
Effect of mAbs to VLA-4 and LFAo I on Neutrophit Accumu- 
lation in Dermal Inflammatory  Reactions.  The effect of block- 
ing VLA-4 and LFA-1 on PMN  migration to inflamed skin 
was  also  determined.  As  shown in  Fig.  6,  treatment with 
anti-~x  4 had no effect on neutrophil accumulation to ZAS, 
LPS, and poly I:C, and produced a small decrease in migra- 
tion to TNF-ci. Anti-LFA-1 alone also caused only a small 
decrease in neutrophil accumulation to some of the lesions, 
whereas  the  combination  of blocking  both  VLA-4  and 
LFA-1 inhibited neutrophil accumulation by 35-70%, with 
the  greatest  effect  observed  in  response  to  TNF-c~.  The 
combination of blocking both VLA-4  and Mac-1  was  no 
more  effective  than  VLA-4  alone  (data  not  shown).  Al- 
though blocking both VLA-4 and LFA-1 was not as effec- 
tive as inhibiting LFA-1 and Mac-1 in migration to cutane- 
ous inflammation (Fig. 2), these results showed that VLA-4 
on neutrophils could mediate part of the accumulation in cu- 
taneous inflammation, especially when LFA-1 was blocked. 
Effect of VLA-4 and Combined  CD18 Blockade  on Neutro- 
phil Accumulation in Arthritic Joints.  Blockade  of the CD18 
integrins  only  partially  inhibited neutrophil  migration  to 
inflamed joints, therefore the effect of blocking VLA-4,  as 
well, was also examined (Fig. 7). Blocking VLA-4, LFA-1, 
and Mac-1  was  not different from blocking the  combina- 
tion of LFA-1  and Mac-1.  However,  the addition of anti- 
VLA-4 to  anti-CD18 treatment further decreased  neutro- 
phil accumulation to  the talar,  hindpaw,  and carpal joints, 
and this decrease was significantly greater in the case of the 
larger joints of the hind limbs. This combined VLA-4 and 
CD18  blockade  inhibited  neutrophil  accumulation  into 
these joints by 70-83%, and suggested that VLA-4 contrib- 
uted to a component of the CD18-independent neutrophil 
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a component of ~25% that might be independent of these 
four integrins. 
Effect of VL#I-4 and CD18 Blockade on Neutrophil Accumu- 
lation in Dermal Inflammation.  The effect of  VLA-4 and CD18 
integrin blockade  on  neutrophil migration to  dermal in- 
flammation is shown in Fig. 8. Treatment with anti-VLA-4 
plus anti-Mac-1 and anti-LFA-1 was significantly more in- 
hibitory than blockade of the  combination of LFA-1  and 
Mac-1.  Similarly,  treatment  with  anti-VLA-4  and  anti- 
CD18 was significantly  more effective than blocking CD18 
alone. Anti-VLA-4 plus anti-CD18 inhibited 95-98.5% of 
the  neutrophil accumulation in the  cutaneous inflamma- 
tory sites,  suggesting that virtually all of the neutrophil mi- 
gration was mediated by these integrins. 
Figure 4.  The  effect of mAb to 
VLA-4 and  LFA-1 on  neutrophil 
migration to arthritic  joints. Animals 
with arthritis as in Fig. 1 were in- 
jected intravenously  with anti-VLA- 
4  (mAb TA-2), anti-LFA-1 (mAb 
TA-3), a combination of anti-VLA- 
4 plus anti-LFA-1, or control mAb 
as indicated. Immediately  afterward, 
labeled neutrophils were given and 
their accumulation in the indicated 
joints was measured after 2 h and is 
expressed as  in Fig.  1.  Values are 
mean  -+  SEM  of 5-17  animals in 
each group. +P <0.05,  xp <0.01, 
*P <o.ool. 
It should also  be pointed out that in spite  of this  pro- 
found suppression of neutrophil accumulation in the  der- 
mal inflammatory sites, migration in these same animals to 
arthritic joints was  only partially suppressed,  and the level 
of circulating labeled blood neutrophils was actually slightly 
(~13%) increased. 
Discussion 
Neutrophil migration out of blood vessels is thought to 
involve an initial tethering and rolling adhesion to the vas- 
cular endothelium, a G-protein mediated activation of the 
neutrophil, and firm adhesion mediated by neutrophil inte- 
grins  (1,  2).  Several  studies,  including  our  own,  have 
shown that the CD18 integrins, notably LFA-1 and Mac-l, 
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Figure 5.  The effect of treatment 
with  antibody  to  VLA-4 and  to 
Mac-1 on neutrophil migration to 
arthritic  joints. Animals  with arthritis 
as in Figs. 1 and 4 were injected in- 
travenously with anti-VLA-4 (mAb 
TA-2), anti-Mac-1 (OX-42), anti- 
VLA-4 plus anti-Mac-I, or control 
mAb. Labeled neutrophils were in- 
jected intravenously  and neutrophil 
accumulation  was measured after 2 h 
and is expressed as in Figs. 1 and 4. 
Values are mean + SEM of 5-17 an- 
imals in each group. Figure 6.  The effect ofanti-VLA-4 and anti-LFA-1 on 
neutrophil migration to dermal inflammation. Arthritic rats 
were  given an i.v.  injection of anti-VLA-4,  anti-LFA-1, 
anti-VLA-4 plus anti-LFA-1, or control mAb, and imme- 
diately thereafter labeled neutrophils were injected intrave- 
nously and cutaneous inflammatory reactions were induced 
by i.d. injection of 50% ZAS, 10 ng TNF-ct, 1 ng LPS, or 
200 ng poly I:C per site as outlined in Fig. 2. The labeled 
cells were allowed to accumulate in the skin sites for 2 h. 
Values are mean +  SEM of 5-17 animals in each group. 
+P <0.05, xp <0.01, and *P <0.001. 
can  mediate  neutrophil  adhesion  and  in  vivo  neutrophil 
migration to inflammatory sites  (11-14).  As reported here, 
80--90% of the neutrophil infiltration in dermal inflamma- 
tory  lesions  could  be  inhibited  by  blocking  LFA-1  and 
Mac-1  or all three  members of the  CD18  family. In con- 
trast,  a  few investigations have also shown that neutrophils 
can  utilize  CD18-independent  mechanisms  for  migration 
to  the lung (14)  and peritoneum (10),  and to  the inflamed 
joint (16).  These  studies show that 25-50%  of the neutro- 
phil accumulation in adjuvant arthritis was  not inhibitable 
by anti-CD18 mAb treatment,  even though this treatment 
inhibited >90%  of the  accumulation in dermal inflamma- 
tion in the same animals (Figs. 1 and 2). Our previous stud- 
ies also showed that neutrophil migration to an intra-artic- 
ular delayed-type  hypersensitivity reaction was  also  CD18 
independent whereas  migration to  intra-articular IL-1  in- 
jection  was  CD18  dependent  (26).  These  findings  sug- 
gested  that  neutrophils  utilized  additional  adhesion  path- 
ways  for  infiltration in adjuvant arthritis.  Since monocyte 
migration  to  inflamed joints  was  highly  dependent  upon 
VLA-4, we wished to  determine whether VLA-4 on neu- 
trophils  might  contribute  to  the  CD18-independent neu- 
trophil accumulation in arthritis. 
The findings reported here are novel in that they are the 
first  to  demonstrate  the  expression  of ct  4  integrins  on  rat 
blood neutrophils, the first to  demonstrate that the VLA-4 
on  neutrophils  is  functional and  mediates,  together  with 
the  CD18  032)  integrins, part  of the  migration of neutro- 
phils to  inflamed joints and dermal inflammation, and that 
in addition to the CD18 and ot  4 integrin pathways, neutro- 
phil  accumulation  in  arthritis  involves  at  least  one  addi- 
tional CD18- and VLA-4-independent pathway. 
Figure  7.  The  effect of  Ab  to 
VLA-4 and CD18 integrins on neu- 
trophil  migration  to  arthritic joints. 
Animals  with arthritis as in Figs. 1 and 
4  were  injected  intravenously  with 
anti-VLA-4, anti-CD  18, anti-Mac-  1 
plus anti-LFA-1, or combinations of 
anti-VLA-4  with  anti-CDl8  and 
anti-LFA-1 plus anti-Mac-1  or con- 
trol mAbs. 111In-labeled  blood neu- 
trophils were  injected  intravenously 
and neutrophil accumulation  in the 
joints was measured after 2 h and is 
expressed as  in  Fig.  1.  Values are 
mean  -+  SEM  of 5-17  animals in 
each group.  +P  <0.05,  xp  <0.01, 
and *P <0.001. 
2180  Very Late Antigen 4 Mediates Neutrophil Migration Figure 8.  The effect of blocking VLA-4 and CD18 in- 
tegrins on neutrophil migration to dermal inflammation. In 
the animals in Fig. 7, immediately  after i.v. injection of the 
mAbs and labeled blood neutrophils, cutaneous inflamma- 
tory reactions were induced by the i.d. injection of 50% 
ZAS, 10 ng TNF-ot, 1 ng LPS, and 200 ng poly I:C per 
site. The labeled cells were allowed to accumulate in the 
skin sites for 2 h. Values are mean +  SEM of 5-17 animals 
in each group. +P <0.05, xp <0.01, *P <0.001. 
Our studies showed that virtually all of the neutrophils in 
the blood  react with  an  anti-or  4 mAb,  TA-2  (Fig.  3).  Al- 
though ot  4 can associate with [31 and [37 to form VLA-4 and 
0t4[37, LPAM-1, the latter has only been found on lympho- 
cytes and  is  absent  from both  neutrophils  and  monocytes 
(28).  Therefore,  the  ot  a integrin  on the  neutrophil  in  our 
studies is most likely VLA-4. 
Eosinophils,  monocytes,  and  lymphocytes  all  express 
VLA-4,  which  can  mediate  adhesion  to  cytokine-stimu- 
lated endothelium by binding to the vascular cell adhesion 
molecule  1 (VCAM-1)  on endothelial  cells (8,  22, 29-34). 
The  TA-2  mAb  reacts  with  VLA-4,  blocks  its  adhesive 
function, and inhibits  the migration of T  lymphocytes and 
monocytes to inflammatory reactions  (8,  22, 23). Blocking 
ot  a with TA-2 alone produced only a small decrease in neu- 
trophil migration to i.d. TNF-ot and had no effect on accu- 
mulation  in  inflamed joints.  This  suggests  that,  by  itself, 
VLA-4 plays  a  minor  role  in  neutrophil  accumulation  in 
most  of the  inflammatory  sites  examined.  However,  the 
functional importance of  VLA-4 could be seen when LFA-1 
was also blocked with an cx  t  (LFA-1)-specific mAb. Block- 
ing VLA-4 significantly decreased neutrophil  migration to 
inflamed joints by 60-75% ifLFA-1 was also blocked (Fig. 
4). Similarly, neutrophil migration to the dermal inflamma- 
tory sites  was  also  inhibited  by blocking VLA-4 together 
with  LFA-1,  although  the  magnitude  of this  effect  de- 
pended  on the inflammatory stimulus  in the skin  (Fig.  6). 
This  suggests  that VLA-4 on neutrophils  is  functional.  In 
addition,  VLA-4 can act as an alternate  adhesion  pathway 
to LFA-1, since blocking both VLA-4 and LFA-1  was re- 
quired for significant inhibition ofneutrophil accumulation 
in  most  of the  inflammatory  tissues.  The  effect  of dual 
VLA-4  and  LFA-1  blockade  appeared  to  be  greater  on 
neutrophil  accumulation  in  inflamed joints  and  TNF-cx- 
injected  skin  than  in  the  other dermal  inflammatory sites. 
Since  previous  studies  have  shown  that  TNF-ot  is  a  key 
mediator  of neutrophil  migration to joints  in adjuvant ar- 
thritis  (35),  the marked  effect of dual blockade  of VLA-4 
and LFA-1  in adjuvant arthritis  and cutaneous TNF-0~ re- 
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actions and anti-VLA-4 alone on i.d.  TNF-ot might be the 
result of more efficient utilization by neutrophils of VLA-4 
to bind to VCAM-1, which is strongly induced on endo- 
thelium by TNF-el (36, 37). 
These  findings  regarding  neutrophil  migration  in  adju- 
vant arthritis  are similar to those  observed with monocyte 
recruitment to arthritic joints.  Both VLA-4 and the CD18 
integrins, particularly LFA-1, mediate monocyte accumula- 
tion  in  inflamed joints  (9).  In addition,  monocyte migra- 
tion to dermal inflammation is much more strongly inhib- 
ited by blocking CD18 integrins than migration to arthritic 
joints, where VLA-4 appears to be more important. 
Blocking Mac-1  alone,  or in combination with VLA-4, 
did not significantly inhibit neutrophil accumulation to ei- 
ther inflamed joints or skin (Figs.  1 and 2),  suggesting that 
LFA-1 is sufficient to allow near normal neutrophil migra- 
tion.  However,  blocking  both  LFA-1  and  Mac-l,  or  all 
three  CD18 integrins  (with  anti-132 mAb) inhibited  >90% 
of the  neutrophil  migration  to  dermal  inflammation,  and 
50-75%  of the  migration  to  arthritic joints.  Anti-VLA-4 
treatment further inhibited neutrophil migration to dermal 
inflammation,  such  that  neutrophil  accumulation  in  cuta- 
neous sites  was nearly abolished  (Fig.  8).  Blocking VLA-4 
also  enhanced the  effect of anti-CD18  treatment  on neu- 
trophil accumulation in arthritic joints  (Fig. 7). This effect, 
however, was only partial. The increased inhibition ofneu- 
trophil accumulation with combined CD18/VLA-4 block- 
ade further supports the contribution of VLA-4 to neutrophil 
accumulation  in  arthritic joints  and  dermal  inflammation. 
The contribution of the CD18 integrins and VLA-4 in neu- 
trophil migration to skin again parallels their roles in mono- 
cyte migration,  although  a  larger proportion  of monocyte 
migration to dermal inflammation is VLA-4 dependent  (9). 
Interestingly,  anti-VLA-4  in  combination  with  anti- 
LFA-1 and anti-Mac-1  was no more effective at inhibiting 
neutrophil accumulation in joints than blockade of the lat- 
ter  two  integrins,  whereas  the  addition  of anti-VLA-4 to 
anti-CD18  treatment  was more  effective than  anti-CD18 
alone  (Fig.  7).  Although  differences  in  Ab  affinity  and blocking activity of the anti-LFA-1,  anti-Mac-i,  and anti- 
CD18  mAbs may explain these results,  one possible expla- 
nation  for  the  enhanced  effectiveness  of anti-CD18  plus 
anti-VLA-4  treatment  may  be  that  CDllc/CD18  may 
have an additional  role in neutrophil migration in adjuvant 
arthritis. 
Finally, one important result from these studies is the fact 
that neutrophll  accumulation  in joints in adjuvant arthritis 
is not entirely abolished by blocking CD18  and VLA-4 in- 
tegrins,  even  though  this  treatment  can  virtually  abolish 
neutrophll accumulation in dermal inflammation. Our pre- 
vious studies demonstrated that there is a CD18-independent 
neutrophil  migration  to  arthritic  joints,  and  CD18-inde- 
pendent  migration  was  observed  to  delayed-type  hyper- 
sensitivity  reactions  in joints  (16,  26).  The  current  report 
demonstrates  that  VLA-4  contributes  to  a  portion  of the 
CD18-independent  migration, but that another pathway is 
probably  also  involved.  The  adhesion  pathway  mediating 
this migration is not clear. The selectins, L-, E-, and P-selec- 
tin, which can mediate initial tethering ofleukocytes to the 
vascular endothelium,  are not thought to be able to medi- 
ate the firm leukocyte adhesion required for transendothelial 
migration (1, 2). VLA-5 and VLA-6 have recently been re- 
ported  to  be  also  present  on  neutrophils,  and  to  mediate 
binding  to  fibronectin  and  laminin  and  migration  across 
synovial fibroblast barriers  (17,  18,  38).  Neutrophil  adhe- 
sion  via  these  integrins  to  extracellular  matrix  proteins 
might  contribute  to part of the  neutrophil  infiltration  in a 
chronically inflamed tissue such as the joint in adjuvant ar- 
thritis,  in  contrast  to  an  acute  dermal  inflammatory  reac- 
tion.  However,  there  is  no  evidence  that  these  integrins 
mediate cell adhesion before transendothelial  migration. 
A  recent in vitro study has suggested that human  blood 
neutrophils,  stimulated  with  chemotactic  factors  in  the 
presence of dihydrocytochalasin B, can express VLA-4 (39). 
Similarly,  transendothelial  migration  by neutrophils  could 
also result in increased VLA-4 expression.  Our studies sug- 
gest  that  in  vivo,  even  in  the  absence  of a  microfilament 
disrupting  agent  such  as  cytochalasin,  rat neutrophils  have 
functional VLA-4, and that this VLA-4 may be particularly 
important in migration to selected inflammatory sites. 
Other  investigations  have  also  demonstrated  CD18- 
independent  neutrophil migration to some types of inflam- 
mation in the lung and the peritoneal cavity (10,  14). In the 
lung, the role of VLA-4 in neutrophil accumulation has not 
been examined, whereas in peritoneal inflammation in rab- 
bits, blocking both VLA-4 and CD18  inhibited neutrophil 
accumulation,  although  the basis of this  effect is unknown 
(10). Recent studies by A. Issekutz (40) have demonstrated 
that  human  blood  neutrophils  in  vitro  can  migrate  across 
unstimulated  endothelium  in response to C5a in a  CD18- 
dependent  manner,  but  that  migration  across  cytokine- 
stimulated  endothelium  in  the  presence  of C5a  was  par- 
tially CD 11/CD18  independent  and was not inhibitable by 
mAb to VLA-4. This suggests that, similar to the migration 
of rat  neutrophils  to  inflamed joints,  human  neutrophils 
also demonstrate a CD18- and VLA-4-independent  migra- 
tion under the appropriate conditions.  The mechanism op- 
erative  in  this  migration,  with  human  or  rat  neutrophils, 
awaits further characterization. 
In  conclusion,  our  studies  have  demonstrated  that  rat 
blood  neutrophils  express  ot  4 integrins  and  that  these  are 
functional and mediate, together with [32 integrins, virtually 
all  of the migration to cutaneous  inflammation, but migra- 
tion  to  inflamed joints  involves  not  only  [32 and  0/.  4 inte- 
grins,  but  also  another pathway.  The  identification  of this 
additional  pathway and the full range of receptors  mediat- 
ing the  migration  of neutrophils  in different  inflammatory 
situations is yet to be fully clarified. 
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